Skip to content
MedsAcross

Alternatives

Alternatives to Tyruko 300 mg/15 mL injection

1 other presentations of Natalizumab 300 mg/15 mL injection

There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Natalizumab), strength (300 mg/15 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.

Side by side

The first row is the medicine you came from.

MedicineManufacturerRegisterPacksStorageLead timeDocumentsAvailability
Tyruko 300 mg/15 mL injectionThis pageIntravenousSandozUS FDA1 vial of 15 mLStore diluted TYRUKO solution refrigerated at 2°C to 8°C (36°F to 46°F).On request—Available on request
Tysabri 300 mg/15 mL injectionIntravenousBiogenUS FDA1 vial of 15 mLStore diluted TYSABRI solution refrigerated at 2°C to 8°C (36°F to 46°F)On request—Available on request

This is a biological medicine. Products from other makers are biosimilars, not identical copies, and switching between them follows the prescriber's and regulator's rules.

Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Back to Tyruko 300 mg/15 mL injection

Not sure which maker to choose?

Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.